Literature DB >> 16078034

Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease.

Jacek Treliński, Krzysztof Chojnowski, Magdalena Kurenko-Deptuch, Marek Kasznicki, Ewa Bernatowska, Tadeusz Robak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16078034     DOI： 10.1007/s00277-005-1094-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  Chronic granulomatous disease as a risk factor for autoimmune disease.

Authors:  Suk See De Ravin; Nora Naumann; Edward W Cowen; Julia Friend; Dianne Hilligoss; Martha Marquesen; James E Balow; Karyl S Barron; Maria L Turner; John I Gallin; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2008-09-26       Impact factor: 10.793

2.  B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.

Authors:  Kabir Matharu; Kol A Zarember; Beatriz E Marciano; Douglas B Kuhns; Christine Spalding; Mary Garofalo; Thomas Dimaggio; Tyra Estwick; Chiung-Yu Huang; Danielle Fink; Debra L Priel; Thomas A Fleisher; Steven M Holland; Harry L Malech; John I Gallin
Journal:  Clin Immunol       Date:  2013-05-22       Impact factor: 3.969

Review 3.  Inflammatory manifestations in chronic granulomatous disease (CGD).

Authors:  S D Rosenzweig
Journal:  J Clin Immunol       Date:  2008-01-12       Impact factor: 8.317

Review 4.  NADPH Oxidase Deficiency: A Multisystem Approach.

Authors:  Giuliana Giardino; Maria Pia Cicalese; Ottavia Delmonte; Maddalena Migliavacca; Boaz Palterer; Lorenzo Loffredo; Emilia Cirillo; Vera Gallo; Francesco Violi; Claudio Pignata
Journal:  Oxid Med Cell Longev       Date:  2017-12-21       Impact factor: 6.543

5.  Rapidly progressive IgA vasculitis-associated nephritis successfully treated with immunosuppressive therapy in an adolescent with chronic granulomatous disease.

Authors:  Mari Tanaka; Keisuke Taniguchi; Sho Miki; Sachio Iwanari; Masaki Ikeda; Masafumi Hasui; Hiroya Takeoka
Journal:  CEN Case Rep       Date:  2021-03-08

6.  Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.

Authors:  Paolo Fiorina; Andrea Vergani; Shirine Dada; Mollie Jurewicz; Masie Wong; Kenneth Law; Erxi Wu; Ze Tian; Reza Abdi; Indira Guleria; Scott Rodig; Kyri Dunussi-Joannopoulos; Jeffrey Bluestone; Mohamed H Sayegh
Journal:  Diabetes       Date:  2008-08-08       Impact factor: 9.461
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.